International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2020 - Volume 24, Number 3
View All Articles in Issue

Page(s): 230

Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, sildenafil, formulation, impotence, erectile dysfunction, penis, phosphodiesterase type 5 inhibitor, smooth muscle relaxation, corpus cavernosum

Related Categories: FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Allen Loyd V Jr	May/Jun 2020 Pg. 230
Sildenafil Citrate 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 306
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Allen Loyd V Jr	May/Jun 2019 Pg. 236
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol McKettrick Greg, Yoch Doug	Jan/Feb 2021 Pg. 18-23
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Fields Shannon W	Mar/Apr 2007 Pg. 122-124
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Cheung Matthew, Zhao Fang, Dave Vivek S	Jan/Feb 2021 Pg. 82-87
Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension Allen Loyd V Jr	May/Jun 2019 Pg. 230
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Davidson Gigi S	Nov/Dec 2006 Pg. 405-408
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Wung Deanna	Jan/Feb 2013 Pg. 24-27
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C	May/Jun 2016 Pg. 247-249
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S	Jan/Feb 2021 Pg. 73-81
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Riepl Mike	Sep/Oct 2021 Pg. 372-377
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Nov/Dec 2019 Pg. 492
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Allen Loyd V Jr	Jan/Feb 2020 Pg. 56
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report McKettrick Greg, Yoch Doug	Mar/Apr 2021 Pg. 94-98
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 45
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Return to Top